Under the terms of the agreement, the Company has the right to enter into exclusive negotiations with Yeda to complete a license agreement to commercialize (i) a diagnostic and/or prognostic tool for Aramchol and/or (ii) a diagnostic and/or ... FirstWord Pharma, 1 month ago
GALMED PHARMACEUTICALS : and Weizmann Institute of Science to enter a research collaboration agreement to assess Aramchol effects on microbiome - 4 Traders, 1 month ago
More from: WorldNetDaily, Nasdaq...and 12 other sources
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, announces the grant by the European Patent Office of the ...PharmaBiz, 2 months ago TxCell Exercises Option from Weizmann Institute of Science Following Effective Grant of Broad CAR-Treg Patent in Europe Wallstreet Online, 2 months ago BRIEF-TxCell exercises option from Weizmann institute Reuters UK, 2 months ago
PHILADELPHIA & REHOVOT, Israel--(Business Wire)--Rosetta Genomics Ltd. (NASDAQ:ROSG), a leading developer and provider of microRNA-based and other molecular diagnostic testing services, announces that the United States Patent and Trademark Office ...Digital Journal, 1 month ago Rosetta Genomics gets US patent for microRNA-based ovarian cancer treatment PharmaBiz, 1 month ago Rosetta Genomics Gets Patent Allowance For microRNA-based Ovarian Cancer Treatment Yahoo! Finance, 1 month ago
UCLA has named Amir Naiberg associate vice chancellor for the Office of Intellectual Property and Industry Sponsored Research ,and president and CEO of Westwood Technology Transfer. Naiberg, who joined UCLA August 3, leads the office thatoversees ...UCLA News, 1 week ago
on your WebpageAdd Widget >Get your members hooked!